Download PDF
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2022; 06(03): 163-169
DOI: 10.1055/s-0041-1740570
Original Article

Percutaneous Cryoablation of Renal Tumors: Initial Indian Experience

Ujjwal Gorsi
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Rishabh Jain
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Akash Bansal
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Naveen Kalra
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Mandeep Kang
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Sreedhara B. Chaluvashetty
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Ravimohan Suryanarayan Mavuduru
2   Department of Urology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Santosh Kumar
2   Department of Urology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Shrawan K. Singh
2   Department of Urology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
,
Manavjit Singh Sandhu
1   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Purpose The purpose of this study was to report short-term outcomes of cryoablation of early-stage renal tumors (T1a and T1b) at a tertiary hospital in India.

Methods This was a retrospective study of consecutive patients who underwent cryoablation for renal cell carcinoma (RCC) from November 2018 to June 2020. Cryoablation was performed under combined ultrasound and computed tomography guidance using a helium-argon cryoablation system. Tumor number, size, location, nephrometry score, relationship of the tumor with pelvicalyceal system, and adjacent organs were tabulated, and technical and clinical success evaluated. Early and late recurrence and complications were also assessed.

Results Eleven patients (median age: 62 years) with 11 tumors underwent cryoablation. The mean tumor size was 2.58 cm (range: 1.62–5.62 cm) with 10 lesions being T1a and one lesion T1b. Tissue sampling was done in 9/11 patients, 3 were papillary RCC and the rest, clear cell RCC. In two patients, the tumor was completely endophytic, three patients had partially endophytic tumors while 6 patients had exophytic lesions. The median nephrometry score was 6 (range: 4–11, Mode 4). Technical success was achieved in all patients. Complete response was achieved in 81% (9/11) of the patients at 1-month follow-up. Median follow-up period was 6 months. Two patients showed residual disease on follow-up imaging at 1 and 3 months, respectively.

Conclusion Cryoablation is a promising, relatively new minimally invasive therapy for treating small renal tumors in India. It is safe, technically feasible, and shows excellent short-term efficacy.

Keywords

cryoablation - renal cell carcinoma - ablation

Financial Disclosure

None.




Publication History

Article published online:
11 January 2022

© 2022. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Joshi A, Anand A, Prabhash K. et al. Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India. Indian J Cancer 2017; 54 (04) 601-604
    CrossrefPubMedGoogle Scholar
  • 2 Silverman SG, Israel GM, Trinh Q-D. Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 2015; 275 (01) 28-42
    CrossrefPubMedGoogle Scholar
  • 3 Aoun HD, Littrup PJ, Jaber M. et al. Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift?. J Vasc Interv Radiol 2017; 28 (10) 1363-1370
    CrossrefPubMedGoogle Scholar
  • 4 Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol 2014; 37 (06) 1494-1499
    CrossrefPubMedGoogle Scholar
  • 5 Seager M, Kumar S, Lim E, Munneke G, Bandula S, Walkden M. Renal cryoablation – a practical guide for interventional radiologists. BJR 2020
    PubMedGoogle Scholar
  • 6 Fernando A, Fowler S, O'Brien T. British Association of Urological Surgeons (BAUS). Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit. BJU Int 2016; 117 (06) 874-882
    CrossrefPubMedGoogle Scholar
  • 7 Deng W, Chen L, Wang Y. et al. Cryoablation versus partial nephrectomy for clinical stage T1 renal masses: a systematic review and meta-analysis. J Cancer 2019; 10 (05) 1226-1236
    CrossrefPubMedGoogle Scholar
  • 8 Campbell SC, Novick AC, Belldegrun A. et al; Practice Guidelines Committee of the American Urological Association. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182 (04) 1271-1279
    CrossrefPubMedGoogle Scholar
  • 9 Allen BC, Remer EM. Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics 2010; 30 (04) 887-900
    CrossrefPubMedGoogle Scholar
  • 10 Sterrett SP, Nakada SY, Wingo MS, Williams SK, Leveillee RJ. Renal thermal ablative therapy. Urol Clin North Am 2008; 35 (03) 397-414 , viii viii
    CrossrefPubMedGoogle Scholar
  • 11 Zondervan PJ, Buijs M, De Bruin DM, van Delden OM, Van Lienden KP. Available ablation energies to treat cT1 renal cell cancer: emerging technologies. World J Urol 2019; 37 (03) 445-455
    CrossrefPubMedGoogle Scholar
  • 12 Johnson DB, Solomon SB, Su L-M. et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 2004; 172 (03) 874-877
    CrossrefPubMedGoogle Scholar
  • 13 Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (01) 72-80
    CrossrefPubMedGoogle Scholar
  • 14 Erinjeri JP, Clark TWI. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S187-S191
    CrossrefPubMedGoogle Scholar
  • 15 Woolley ML, Schulsinger DA, Durand DB, Zeltser IS, Waltzer WC. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol 2002; 16 (07) 519-522
    CrossrefPubMedGoogle Scholar
  • 16 Young JL, McCormick DW, Kolla SB. et al. Are multiple cryoprobes additive or synergistic in renal cryotherapy?. Urology 2012; 79 (02) 484.e1-484.e6
    CrossrefPubMedGoogle Scholar
  • 17 Atwell TD, Carter RE, Schmit GD. et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol 2012; 23 (01) 48-54
    CrossrefPubMedGoogle Scholar
  • 18 Campbell S, Uzzo RG, Allaf ME. et al. Renal Mass and Localized Renal Cancer: AUA Guideline. J Urol 2017; 198 (03) 520-529
    CrossrefPubMedGoogle Scholar
  • 19 Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter III TC, Lee Jr FT. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol 2008; 191 (04) 1159-1168
    CrossrefPubMedGoogle Scholar
  • 20 Bodily KD, Atwell TD, Mandrekar JN. et al. Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. AJR Am J Roentgenol 2010; 194 (03) 779-783
    CrossrefPubMedGoogle Scholar
  • 21 Wright AD, Turk TM, Nagar MS, Phelan MW, Perry KT. Endophytic lesions: a predictor of failure in laparoscopic renal cryoablation. J Endourol 2007; 21 (12) 1493-1496
    CrossrefPubMedGoogle Scholar
  • 22 Sung GT, Gill IS, Hsu THS. et al. Effect of intentional cryo-injury to the renal collecting system. J Urol 2003; 170 (2 Pt 1): 619-622
    CrossrefPubMedGoogle Scholar
  • 23 Brashears III JH, Raj GV, Crisci A. et al. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. J Urol 2005; 173 (06) 2160-2165
    CrossrefPubMedGoogle Scholar
  • 24 Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation–initial observations. Radiology 2005; 237 (01) 366-370
    CrossrefPubMedGoogle Scholar
  • 25 Atwell TD, Farrell MA, Callstrom MR. et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol 2007; 188 (05) 1195-1200
    CrossrefPubMedGoogle Scholar
  • 26 Gunn AJ, Joe WB, Salei A. et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: safety, technical results, and clinical outcomes. Cardiovasc Intervent Radiol 2019; 42 (07) 970-978
    CrossrefPubMedGoogle Scholar
  • 27 Schmit CH, Callstrom MR, Boorjian SA. et al. A comparison of bleeding complications in patients undergoing percutaneous renal cryoablation using cryoprobes with and without heat-based track ablation. J Vasc Interv Radiol 2018; 29 (06) 874-879
    CrossrefPubMedGoogle Scholar